Call Options

28 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$40.25 - $52.99 $84.7 Million - $112 Million
2,105,300 Added 39.25%
7,468,900 $310 Million
Q1 2024

May 07, 2024

BUY
$47.98 - $54.4 $10.8 Million - $12.3 Million
225,500 Added 4.39%
5,363,600 $291 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $25.8 Million - $30.8 Million
-532,200 Reduced 9.39%
5,138,100 $264 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $131 Million - $147 Million
2,267,200 Added 66.62%
5,670,300 $329 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $58.9 Million - $65.4 Million
-924,600 Reduced 21.36%
3,403,100 $218 Million
Q1 2023

May 16, 2023

BUY
$65.71 - $74.53 $12.9 Million - $14.6 Million
195,600 Added 4.73%
4,327,700 $300 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $17.6 Million - $20.8 Million
-256,300 Reduced 5.84%
4,132,100 $297 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $224,146 - $132 Million
-1,724,200 Reduced 28.21%
4,388,400 $312 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $2.07 Million - $2.28 Million
-28,500 Reduced 0.46%
6,112,600 $471 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $30.9 Million - $37.1 Million
503,200 Added 8.93%
6,141,100 $448 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $35.1 Million - $41 Million
655,300 Added 13.15%
5,637,900 $352 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $31 Million - $36.4 Million
-524,600 Reduced 9.53%
4,982,600 $295 Million
Q2 2021

Aug 11, 2021

BUY
$61.91 - $67.42 $48.9 Million - $53.3 Million
790,200 Added 16.75%
5,507,200 $368 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $13.5 Million - $15.2 Million
-227,200 Reduced 4.6%
4,717,000 $298 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $22.2 Million - $25.1 Million
-384,200 Reduced 7.21%
4,944,200 $307 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $86.1 Million - $95.5 Million
-1,499,900 Reduced 21.97%
5,328,400 $321 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $14.2 Million - $16.6 Million
259,100 Added 3.94%
6,828,300 $402 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $24.4 Million - $35.5 Million
526,000 Added 8.7%
6,569,200 $366 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $85.1 Million - $111 Million
-1,729,300 Reduced 22.25%
6,043,200 $388 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $149 Million - $176 Million
3,475,500 Added 80.88%
7,772,500 $394 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $84 Million - $92.9 Million
-1,882,700 Reduced 30.47%
4,297,000 $195 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $11.7 Million - $13.9 Million
258,300 Added 4.36%
6,179,700 $295 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $21 Million - $27.2 Million
430,100 Added 7.83%
5,921,400 $308 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $25.5 Million - $28.8 Million
-461,900 Reduced 7.76%
5,491,300 $341 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $51.8 Million - $64.6 Million
-1,025,200 Reduced 14.69%
5,953,200 $329 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $88 Million - $101 Million
-1,469,100 Reduced 17.39%
6,978,400 $441 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $48 Million - $52.3 Million
800,900 Added 10.47%
8,447,500 $518 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $422 Million - $487 Million
7,646,600
7,646,600 $487 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.